Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Touchstone commits funds to Ieso Digital Health

12 Sep 2017 07:00

RNS Number : 4276Q
Touchstone Innovations PLC
12 September 2017
 

 

12 September 2017

 

Touchstone Innovations plc

 

Touchstone commits £8m in £18m funding round in Ieso Digital Health

 

Touchstone Innovations plc (AIM: IVO, 'the Group', 'Touchstone') has co-led a £18.0 million funding round in Ieso Digital Health ("Ieso" or "the Company"), the UK's leading provider of online Cognitive Behavioural Therapy (CBT) for the treatment of people suffering from community based mental healthcare conditions, predominantly depression and anxiety.

 

Touchstone has committed £8.0 million to the round, including a loan of £2.0 million from May 2017, which has now converted to equity. Touchstone invested alongside new investor Draper Esprit, who co-led the round, together with existing investor Ananda Social Venture Fund and a number of business angels.

 

Ieso, based in Cambridge, is the largest provider of online CBT in the UK. By the end of 2017, Ieso will have delivered over 100,000 hours of therapy to more than 16,700 patients, within the 9 million patients who have access via clinical commissioning contracts. The Company's proprietary web-based platform provides patients with access to CBT, delivered in real-time by accredited therapists utilising written (typed) conversation directly accessible from their computer, tablet or smartphone.

 

Therapy delivered in this way has been clinically validated in routine NHS service to deliver better results than traditional face-to-face methods, with higher levels of access, patient engagement, therapy session completion and lower drop-out rates. 

 

The new funding will enable Ieso to continue to grow its UK business and accelerate its introduction and expansion in the US, where the Company has achieved significant early traction and recently appointed a new highly-experienced management team.

 

As at 31 January 2017, the Group had a 46.9% interest in the issued share capital of Ieso. Following this new investment Touchstone will hold a 49.3% interest in the Company.

 

Commenting on this funding round, Dan Clark, CEO of Ieso said:

 

"Ieso is creating transformative change in mental health treatment.

 

"An estimated 60% of patients do not seek out mental health services, largely because of stigma and difficulty in accessing care. We've helped eliminate these barriers and are empowering patients by delivering therapy at a time that fits their lifestyles and through devices that are a part of their everyday lives.

 

"This new funding will allow us to continue scaling geographically and innovating our technology by applying artificial intelligence and machine learning to enhance therapist support and further improving patient access."

 

Inga Deakin, Principal at Touchstone and Ieso Board member added:

 

"We first invested in Ieso in 2013. From the outset, we believed that the best way to nurture the business was to demonstrate traction in the UK National Health Service, which has a world-leading CBT delivery infrastructure and ambitious targets for delivery of treatment to patients.

 

"With more than 16,700 patients treated, Ieso has developed outstanding clinical credentials and built a strong evidenced-based platform. The Company has also assembled a highly-experienced management team, comprising world-class artificial intelligence and data scientists, clinicians, therapists and executive leadership.

 

"This new funding round is the largest amount raised by a digital behavioural health business in Europe and will enable the next phase of growth."

 

For further information contact:

 

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

 

Jon Davies, Director of Communications

 

 

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

 

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

 

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

About Touchstone Innovations - www.touchstoneinnovations.com

 

Touchstone Innovations plc (formerly Imperial Innovations Group plc) creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the 'Golden Triangle', the geographical region broadly bounded by London, Cambridge and Oxford.

 

This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

 

Touchstone supports scientists and entrepreneurs in the commercialisation of their ideas through protecting and licensing out intellectual property (through its Technology Transfer subsidiary, Imperial Innovations Limited), by leading the formation of new companies, by recruiting high calibre management teams and by providing investment and encouraging co-investment. Touchstone remains an active investor over the life of its portfolio companies, with the majority of its investment going into businesses in which it is already a shareholder.

 

Since becoming a public company in 2006, Touchstone has raised more than £440 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has drawn down the outstanding £50.0 million from the European Investment Bank (EIB) taking the total loan to £80.0 million.

 

Between admission to AIM (August 2006) and 30 June 2017, Touchstone has invested a total of £364.0 million across its portfolio companies, which have collectively raised investment of more than £1.5 billion.

 

About Ieso Digital Health - https://uk.iesohealth.com/

 

Ieso Digital Health (Ieso) offers real-time one-to-one therapy online for people dealing with depression and anxiety. The Company's proprietary web-based platform enables Cognitive Behavioural Therapy (CBT) to be delivered in real-time by real therapists using written (typed) conversation.

 

Ieso is the largest provider of online CBT in the UK, and has treated more than 16,700 patients and captured over 75 million clinical data units in the company's therapy database. These data are then analysed, with the findings being used to support continuous improvement in the product and in the therapists' performance.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSRAFILLID
Date   Source Headline
24th Jan 20117:00 amRNSResult of equity raise
6th Jan 20111:11 pmRNSResult of General Meeting
9th Dec 201011:10 amRNSDirectors' Dealings
8th Dec 20104:55 pmRNSPublication of Prospectus
7th Dec 20107:09 amRNS£140m equity raising
12th Oct 20107:00 amRNSFinal Results
15th Sep 20104:17 pmRNSNotice of Results
2nd Sep 20109:00 amRNSPortfolio News
25th Aug 20109:00 amRNSPortfolio Company News
20th Aug 20109:00 amRNSFurther portfolio investments
22nd Jun 201010:37 amRNSDirectors' Dealings
1st Jun 20107:01 amRNSSale of portfolio company
27th Apr 20107:00 amRNSInterim Results
23rd Apr 20109:05 amRNSMIT praises Novacem technology
9th Apr 20107:00 amRNSNotice of Results
6th Apr 20108:00 amRNSInvestment in portfolio company
11th Mar 20108:00 amRNSFurther Investment in portfolio company
8th Mar 20104:19 pmRNSChange of Adviser
5th Mar 201011:05 amRNSTR1 - Notification of major interest in shares
3rd Mar 20108:30 amRNSMilestone for Nexeon
2nd Mar 20107:16 amRNSMembrane Extraction Technology sold
1st Mar 20107:00 amRNSInvestment in portfolio company
17th Feb 20107:00 amRNSFurther Investment In PolyTherics
8th Feb 201012:41 pmRNSDirector Dealing
5th Feb 20103:42 pmRNSNotification of Major Interest in Shares
27th Jan 20107:00 amRNSLicence Agreement
19th Jan 20105:58 pmRNSDirector Dealings
19th Jan 201011:47 amRNSAdditional Listing of Shares
21st Dec 200911:32 amRNSBoard Appointment
15th Dec 200912:04 pmRNSResult of AGM
11th Dec 20097:00 amRNSFurther investment in portfolio company
8th Dec 200910:14 amRNSDirector Dealing's
27th Nov 200910:31 amRNSHolding(s) in Company
11th Nov 200911:42 amRNSNotice of AGM
21st Oct 20093:20 pmRNSDirector Dealings
20th Oct 20097:00 amRNSFurther Investment In Portfolio Company
13th Oct 20094:17 pmRNSDirector Dealing
12th Oct 20093:09 pmRNSDirectors' Dealings
8th Oct 20097:00 amRNSFurther Investment in Plaxica
7th Oct 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSInvestment in Portfolio Company
1st Sep 20097:00 amRNSLeads ?2 funding round in Molecular Vision
25th Aug 20093:30 pmRNSNotice of Results
10th Aug 20097:00 amRNSInvestments in portfolio companies
3rd Jul 20097:00 amRNSInvestment in OSspray
26th Jun 20097:00 amRNSDisposal of investment in InforSense
2nd Jun 20094:30 pmPRNHolding(s) in Company
28th May 20098:05 amRNSPortfolio Company IP Trade Sale to Technip
20th May 20097:00 amRNSDirector/PDMR Shareholding
27th Apr 20097:00 amPRNHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.